Tianjin Pharmaceutical Da Ren Tang (SHA:600329) signed an annual distribution agreement with related parties Taiping Pharmaceutical and Zhongxin Pharmaceutical for up to 113 million yuan in product sales through year-end.
The deal covers 10 products including Suxiao Jiuxin Pills for the Tianjin medical market, according to a weekend filing with the Shanghai bourse.